ABLI — Abliva AB Share Price
Last Trade - 00:00- SEK201.66m
- SEK153.68m
- SEK0.21m
Momentum
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | |||
| EPS Growth (f) | |||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | |||
| Price to Tang. Book | |||
| Price to Free Cashflow | |||
| Price to Sales | |||
| EV to EBITDA | |||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | |||
| Return on Equity | |||
| Operating Margin | |||
Financial Summary
| Year End 31st Dec | Unit | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | 0.01 | 0.03 | 0.01 | 0.13 | 0.22 | 0.93 | 0.93 | -38.73% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Health trend(F-Score)
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Abliva AB is a Sweden-based company involved in pharmaceutical industry. The Company focuses on the development of novel treatments for primary mitochondrial diseases.
Directors
- David Laskow-Pooley CHM (63)
- Ellen Donnelly
- Catharina Johansson DCE (54)
- Eskil Elmer CSO (46)
- Cecilia Hofvander (52)
- Magnus Hansson (40)
- Michele Tavecchio
- David Bejker
- Denise Goode
- Magnus Persson (60)
- Jan Tornell (57)
- Last Annual
- December 31st, 2020
- Last Interim
- March 31st, 2021
- Incorporated
- January 1st, 1970
- Public Since
- October 3rd, 2008
- No. of Shareholders
- 12,810
- No. of Employees
- 9
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- OMX Nordic Exchange Stockholm
- Shares in Issue
- 296,340,132
- Address
- Medicon Village, Scheeletorget 1, LUND, 223 81
- Web
- http://abliva.com/
- Phone
- +46 462756220
- Contact
- Cecilia Hofvander
- Auditors
- Mazars SET Revisionsbyra AB
Latest News for ABLI
Upcoming events for ABLI
Q2 2021 Abliva AB Earnings Release
Q3 2021 Abliva AB Earnings Release
Similar to ABLI
ACTIVE BIOTECH ORD
OMX Nordic Exchange Stockholm
ALZECURE PHARMA ORD
OMX Nordic Exchange Stockholm
ANNEXIN PHARMACEUTICALS ORD
OMX Nordic Exchange Stockholm
ASARINA PHARMA ORD
OMX Nordic Exchange Stockholm
BERGENBIO ORD
OMX Nordic Exchange Stockholm
FAQ
As of Today at 19:54 UTC, shares in Abliva AB are trading at SEK0.68. This share price information is delayed by 15 minutes.
Shares in Abliva AB last closed at SEK0.68 and the price had moved by -32.36% over the past 365 days. In terms of relative price strength the Abliva AB share price has underperformed the FTSE Global All Cap Index by -47.48% over the past year.
There is no consensus recommendation for this security.
Abliva AB does not currently pay a dividend.
Abliva AB does not currently pay a dividend.
Abliva AB does not currently pay a dividend.
To buy shares in Abliva AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of SEK0.68, shares in Abliva AB had a market capitalisation of SEK201.66m.
Here are the trading details for Abliva AB:
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: ABLI
Based on an overall assessment of its quality, value and momentum Abliva AB is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Abliva AB is SEK1.40. That is 105.73% above the last closing price of SEK0.68.
Analysts covering Abliva AB currently have a consensus Earnings Per Share (EPS) forecast of -SEK0.22 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Abliva AB. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -16.67%.
As of the last closing price of SEK0.68, shares in Abliva AB were trading -9% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We are not able to find PE ratio data for Abliva AB.
Abliva AB's management team is headed by:
- David Laskow-Pooley - CHM
- Ellen Donnelly -
- Catharina Johansson - DCE
- Eskil Elmer - CSO
- Cecilia Hofvander -
- Magnus Hansson -
- Michele Tavecchio -
- David Bejker -
- Denise Goode -
- Magnus Persson -
- Jan Tornell -
We do not have data on Abliva AB's shareholders